Product Program year 2025 Source: CMS Open Payments

Aeropace Neurostimulation Console

Device Transvenous temporary phrenic nerve stimulator

PDI 00810073210127

Open in the dashboard

General payments

$11,310

60 payments

Research payments

$0

0 payments

Through program year 2025, $11,310 in general payments and $0 in research payments were reported against Aeropace Neurostimulation Console (Transvenous temporary phrenic nerve stimulator).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $11,310 60

Breakdown

Who paid General payments · program year 2025
  1. Lungpacer Medical USA Inc $11,310 60 payments
Top recipients General payments · program year 2025
  1. Ali Ataya Critical Care Medicine · Gainesville, FL $5,725 51% · 1 payment
  2. Joseph Shrager Thoracic Surgery (Cardiothoracic Vascular Surgery) · Palo Alto, CA $2,500 22% · 1 payment
  3. Dustin Fraidenburg Pulmonary Disease · Chicago, IL $438 4% · 1 payment
  4. Anthony Mattox Critical Care Medicine · Memphis, TN $174 2% · 1 payment
  5. David Williams Critical Care Medicine · Memphis, TN $174 2% · 1 payment

The top 5 of 59 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Critical Care Medicine Internal Medicine $6,775 60% · 12 practitioners
  2. Thoracic Surgery (Cardiothoracic Vascular Surgery) $2,569 23% · 4 practitioners
  3. Pulmonary Disease Internal Medicine $1,356 12% · 23 practitioners
  4. Internal Medicine $96 <1% · 3 practitioners
  5. Physician Assistant $86 <1% · 3 practitioners

The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $6,296 56% · 17 recipients
  2. California $2,538 22% · 2 recipients
  3. Tennessee $1,046 9% · 6 recipients
  4. Michigan $456 4% · 12 recipients
  5. Illinois $438 4% · 1 recipient

The top 5 of 14 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

60 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record